Annual EBITDA
-$74.34 M
+$14.31 M+16.14%
December 31, 2023
Summary
- As of February 8, 2025, BOLT annual EBITDA is -$74.34 million, with the most recent change of +$14.31 million (+16.14%) on December 31, 2023.
- During the last 3 years, BOLT annual EBITDA has fallen by -$25.77 million (-53.06%).
- BOLT annual EBITDA is now -556.33% below its all-time high of -$11.33 million, reached on December 31, 2018.
Performance
BOLT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$16.00 M
+$2.57 M+13.85%
September 30, 2024
Summary
- As of February 8, 2025, BOLT quarterly EBITDA is -$16.00 million, with the most recent change of +$2.57 million (+13.85%) on September 30, 2024.
- Over the past year, BOLT quarterly EBITDA has increased by +$2.57 million (+13.85%).
- BOLT quarterly EBITDA is now -85.13% below its all-time high of -$8.64 million, reached on March 31, 2020.
Performance
BOLT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$70.51 M
+$1.72 M+2.38%
September 30, 2024
Summary
- As of February 8, 2025, BOLT TTM EBITDA is -$70.51 million, with the most recent change of +$1.72 million (+2.38%) on September 30, 2024.
- Over the past year, BOLT TTM EBITDA has increased by +$1.72 million (+2.38%).
- BOLT TTM EBITDA is now -649.24% below its all-time high of -$9.41 million, reached on December 31, 2019.
Performance
BOLT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BOLT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.1% | +13.8% | +2.4% |
| 3 y3 years | -53.1% | +13.8% | +2.4% |
| 5 y5 years | -556.3% | +13.8% | +2.4% |
BOLT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +18.8% | at high | +40.1% | at high | +27.3% |
| 5 y | 5-year | -142.7% | +18.8% | -85.1% | +40.1% | -649.2% | +27.3% |
| alltime | all time | -556.3% | +18.8% | -85.1% | +40.1% | -649.2% | +27.3% |
Bolt Biotherapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$16.00 M(-13.8%) | -$70.51 M(-2.4%) |
| Jun 2024 | - | -$18.57 M(+11.7%) | -$72.23 M(-1.1%) |
| Mar 2024 | - | -$16.63 M(-13.8%) | -$73.03 M(-1.8%) |
| Dec 2023 | -$74.34 M(-16.1%) | -$19.30 M(+8.9%) | -$74.34 M(-1.7%) |
| Sep 2023 | - | -$17.72 M(-8.5%) | -$75.62 M(-5.2%) |
| Jun 2023 | - | -$19.37 M(+7.9%) | -$79.81 M(-3.9%) |
| Mar 2023 | - | -$17.95 M(-12.8%) | -$83.08 M(-6.3%) |
| Dec 2022 | -$88.66 M | -$20.58 M(-6.1%) | -$88.66 M(-6.5%) |
| Sep 2022 | - | -$21.91 M(-3.3%) | -$94.79 M(-1.4%) |
| Jun 2022 | - | -$22.65 M(-3.7%) | -$96.11 M(-0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$23.52 M(-12.0%) | -$96.96 M(+5.9%) |
| Dec 2021 | -$91.59 M(+88.6%) | -$26.71 M(+15.0%) | -$91.59 M(+12.3%) |
| Sep 2021 | - | -$23.22 M(-1.2%) | -$81.58 M(+15.6%) |
| Jun 2021 | - | -$23.50 M(+29.5%) | -$70.59 M(+21.5%) |
| Mar 2021 | - | -$18.15 M(+8.7%) | -$58.08 M(+19.6%) |
| Dec 2020 | -$48.57 M(+58.6%) | -$16.70 M(+36.6%) | -$48.57 M(+17.7%) |
| Sep 2020 | - | -$12.23 M(+11.1%) | -$41.28 M(+42.1%) |
| Jun 2020 | - | -$11.00 M(+27.3%) | -$29.05 M(+60.9%) |
| Mar 2020 | - | -$8.64 M(-8.2%) | -$18.05 M(+91.8%) |
| Dec 2019 | -$30.63 M(+170.5%) | -$9.41 M | -$9.41 M |
| Dec 2018 | -$11.33 M | - | - |
FAQ
- What is Bolt Biotherapeutics annual EBITDA?
- What is the all time high annual EBITDA for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics annual EBITDA year-on-year change?
- What is Bolt Biotherapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics quarterly EBITDA year-on-year change?
- What is Bolt Biotherapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics TTM EBITDA year-on-year change?
What is Bolt Biotherapeutics annual EBITDA?
The current annual EBITDA of BOLT is -$74.34 M
What is the all time high annual EBITDA for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high annual EBITDA is -$11.33 M
What is Bolt Biotherapeutics annual EBITDA year-on-year change?
Over the past year, BOLT annual EBITDA has changed by +$14.31 M (+16.14%)
What is Bolt Biotherapeutics quarterly EBITDA?
The current quarterly EBITDA of BOLT is -$16.00 M
What is the all time high quarterly EBITDA for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high quarterly EBITDA is -$8.64 M
What is Bolt Biotherapeutics quarterly EBITDA year-on-year change?
Over the past year, BOLT quarterly EBITDA has changed by +$2.57 M (+13.85%)
What is Bolt Biotherapeutics TTM EBITDA?
The current TTM EBITDA of BOLT is -$70.51 M
What is the all time high TTM EBITDA for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high TTM EBITDA is -$9.41 M
What is Bolt Biotherapeutics TTM EBITDA year-on-year change?
Over the past year, BOLT TTM EBITDA has changed by +$1.72 M (+2.38%)